Below are the most recent publications written about "Hydroxymethylglutaryl-CoA Reductase Inhibitors" by people in Profiles.
-
Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ, Rosenson RS, Sweitzer NK, Timmis A, Vrints C. Medical misinformation: vet the message! Eur Heart J Cardiovasc Pharmacother. 2019 04 01; 5(2):62-63.
-
Bykov K, Mittleman MA, Glynn RJ, Schneeweiss S, Gagne JJ. The Case-Crossover Design for Drug-Drug Interactions: Considerations for Implementation. Epidemiology. 2019 03; 30(2):204-211.
-
Stensrud MJ, Ryalen PC, Røysland K. Sufficient Cause Interaction for Time-to-event Outcomes. Epidemiology. 2019 03; 30(2):189-196.
-
Hennekens CH, Schuttenberg N, Pfeffer MA. Prescription of Aspirin and Statins in Primary Prevention. Prim Care. 2019 Mar; 46(1):13-25.
-
Rogers JR, Sarpatwari A, Desai RJ, Bohn JM, Khan NF, Kesselheim AS, Fischer MA, Gagne JJ, Connolly JG. Effect of Lawyer-Submitted Reports on Signals of Disproportional Reporting in the Food and Drug Administration's Adverse Event Reporting System. Drug Saf. 2019 01; 42(1):85-93.
-
Köhler-Forsberg O, Gasse C, Petersen L, Nierenberg AA, Mors O, Østergaard SD. Statin treatment and the risk of depression. J Affect Disord. 2019 03 01; 246:706-715.
-
Sørensen AL, Hasselbalch HC, Nielsen CH, Poulsen HE, Ellervik C. Statin treatment, oxidative stress and inflammation in a Danish population. Redox Biol. 2019 02; 21:101088.
-
Rea F, Calusi G, Franchi M, Vetrano DL, Roberto G, Bonassi S, Kirchmayer U, Chinellato A, Bettiol A, Sultana J, Mugelli A, Corrao G. Adherence of Elderly Patients with Cardiovascular Disease to Statins and the Risk of Exacerbation of Chronic Obstructive Pulmonary Disease: Evidence from an Italian Real-World Investigation. Drugs Aging. 2018 12; 35(12):1099-1108.
-
Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 2019 01 03; 380(1):11-22.
-
Lan NSR, Fegan PG, Yeap BB, Bell DA, Watts GF. Dyslipidaemia in adults with type 1 diabetes-when to treat? Diabetes Metab Res Rev. 2019 01; 35(1):e3090.